Published in Medical Letter on the CDC and FDA, September 26th, 2004
The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent to that of the reference listed drug, Claritin Syrup, 5 mg5 mL, of Schering Corporation.
Loratadine is the generic equivalent of Scherings long acting tricyclic antihistamine agent Claritin, which has total market sales of $13.5 million (IRI MAT: July 2004).Loratadine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.